{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreig2v3n6ctxpvvluqp72av5tiimuqwvqpqpkkzrof73ostjs3mxjhm",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mlo4j3nxjws2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiek2xm4235qwq4imhlpjakmdvgpmphcil2uhva5mhriwpc7oeljpm"
    },
    "mimeType": "image/jpeg",
    "size": 52874
  },
  "path": "/news/2026-05-immunotherapy-treatment-aggressive-prostate-cancer.html",
  "publishedAt": "2026-05-12T10:20:02.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Researchers at Moffitt Cancer Center report encouraging early results from a phase 2 study examining whether immunotherapy can improve results when added to a radiotherapy-based treatment regimen for men with aggressive prostate cancer. The work, led by Kosj Yamoah, MD, Ph.D., was published in the Journal for ImmunoTherapy of Cancer.",
  "title": "Study suggests immunotherapy may strengthen treatment for aggressive prostate cancer"
}